Merck Animal Health’s Post

Today, we announced the completion of the acquisition of Elanco's aqua business, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements.    This acquisition will position us to transform the aquaculture industry with a robust and comprehensive portfolio across warm water, cold water, vaccines, anti-parasitic treatments, water supplements and nutrition. https://bit.ly/3Lh68kp

  • No alternative text description for this image
Jeff Smith

National Sales Manager at Airlite Plastics Co.

5mo

Awesome...let me know if there is anything we can help with

Wayne Chittick

Associate Director, Biotechnology Services at Merck

5mo

It's an exciting chapter in Merck AH! 🐟

Like
Reply
Pamela Mitchell

Manager, Veterinary Strategic Partnerships at Dechra Pharmaceuticals PLC

5mo

Moving forward! Congratulations!

Like
Reply
Steve Braun

Brandmeyer Enterprises, LLC

5mo

Congratulations Kevin! Hope you and the family are doing well

Like
Reply
Robin Prtina

Executive Sales Specialist at Anivive Life Sciences

5mo

Love this

Like
Reply
Gabriela Marrero

Degree in Social Communication, journalist, specialized in digital marketing and content creation.

5mo

Keep growing!

Like
Reply
E.A. (Gene) M.

Sr. Specialist, Technology Risk Management @ IT Risk Center of Excellence

5mo

Great news!

Like
Reply
Ulrike Kirsten Buchwald

Vaccines Therapeutic Area Head - Translational Medicine| Associate VP | Physician-Scientist | Infectious Diseases | Public Health

5mo

Great news!

See more comments

To view or add a comment, sign in

Explore topics